Opening book details…
Can I read Guidelines on Iron Chelation Therapy in Patients with Myelodysplastic Syndromes and Transfusional Iron Overload on EtoBox?
Guidelines on Iron Chelation Therapy in Patients with Myelodysplastic Syndromes and Transfusional Iron Overload by Norbert Gattermann is a Medicine article available to read on EtoBox.
What is Guidelines on Iron Chelation Therapy in Patients with Myelodysplastic Syndromes and Transfusional Iron Overload about?
Experts believe that iron overload is an important problem which could be avoided with suitable treatment. Guidelines on treating myelodysplastic syndromes (MDS) include sections on using iron chelation therapy to prevent or ameliorate transfusional iron overload. The proportion of MDS patients who may benefit from iron chelation therapy is 35-55%, depending on the length of survival necessary for iron to accumulate to a detrimental level. Candidates for iron chelation are mainly patients with dyserythropoietic and cytopenic subtypes of disease, which fall into the International Prognostic Scoring System (IPSS) Low-risk or Intermediate-1-risk categories, with median survival of 3-6 years.
Who reads Guidelines on Iron Chelation Therapy in Patients with Myelodysplastic Syndromes and Transfusional Iron Overload?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Norbert Gattermann
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0145-2126)
- Published
- 2007
- Language
- EN
- Field
- Medicine (Health Sciences)